To mark the event, researchers from ARCSHS got together with the CEO of Hepatitis Australia Carrie Fowlie to share and discuss findings from three recent social research projects on hepatitis C. These projects cover a range of issues relating to hepatitis C in Australia in the age of viral elimination, including:

• People’s lived experiences of treatment for hepatitis C;
• Experiences of telehealth care delivery for hepatitis C; and
• The post-cure lives and needs of people treated for hepatitis C.

The discussion was hosted by Associate Professor Kate Seear, Research Lead of the Gender, Law and Drugs (GLaD) program at ARCSHS, and was chaired by GLaD researcher Dr Dion Kagan. It featured contributions from Dr Adrian Farrugia, a member of the Drugs, Gender and Sexuality (DruGS) team at ARCSHS, GLaD researchers Emily Lenton and Dr Sean Mulcahy, and Dr Renae Fomiatti, from the School of Humanities and Social Sciences at Deakin University, and an Adjunct Research Fellow at ARCSHS.